Kymera Therapeutics (KYMR) PT Raised to $129 at Canaccord
(Updated - June 26, 2026 8:15 AM EDT)
Canaccord analyst Edward Nash raised the price target on Kymera Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Canaccord analyst Edward Nash raised the price target on Kymera Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
